AMEX:XBI   SPDR Series Trust SPDR S&P Biotech ETF
3
Is Biotech headed back to retest YTD highs at $72.50? The potential is there after a bullish bounce at the 50 Moving Average. =)

Trade Accordingly.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.